Remus Pharmaceuticals Limited (NSE:REMUS)
India
· Delayed Price · Currency is INR 878.55
-11.25 (-1.26%)
At close: Jul 10, 2025
Remus Pharmaceuticals Revenue
In the fiscal year ending March 31, 2025, Remus Pharmaceuticals had annual revenue of 6.20B INR with 191.44% growth. Remus Pharmaceuticals had revenue of 3.48B in the half year ending March 31, 2025.
Revenue
6.20B
Revenue Growth
+191.44%
P/S Ratio
1.67
Revenue / Employee
n/a
Employees
48
Market Cap
10.35B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,553.24B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Life Insurance Corporation of India | 8,901.58B |